Worldwide, there is an increase in detection of cancer incidences, of Breast cancer, Prostate cancer, and Lung cancer, due to a rise in awareness level. Besides rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the adoption of biopsy devices. Many countries hold programs for the early diagnosis of breast cancer. Therefore, such initiatives will stimulate the adoption rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business. According to Renub Research, the Global Biopsy Devices Market is projected to reach US$ 3.5 Billion by 2027.
With improved screening and diagnostic techniques, biopsy devices are an integral part of the diagnostic workup for many medical conditions. It is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of disease, usually cancerous and inflammatory conditions. This diagnostic procedure is performed by radiologists, surgeons and interventional cardiologists. Biopsies can be done on any organ using specific biopsy devices as a confirmatory test for cancer and celiac diseases. According to the World Cancer Report, cancer rates could further increase by 50% to 15 Million new cases in 2020. Therefore, the increasing incidence of cancer cases and developments in biopsy devices witness high growth.
Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=biopsy-devices-market-global-forecast-p.php
Based on Product – Needle-based Biopsy holds the Largest Market Share
The biopsy devices market has been segmented into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and others. Needle-based biopsy holds the leading market share due to the increasing demand for Fine Aspiration Needles and Core Needles for acquiring samples from soft tissues of internal organs, an application such as breasts, Prostate, and lungs. As per Statista, breast cancer will make up to 27.7 percent of all the new cancer cases in women in Asia in 2020.
In addition, Guidance Systems, Biopsy Guns, Reagents and other devices are used in extensive applications across numerous healthcare institutions, such as Diagnostic Center, Hospitals and others. Advanced healthcare infrastructure and the expanding prevalence of infections have positively impacted biopsy devices growth over the projected timeframe. This is attributed to the growth in the healthcare sector in emerging economies, the rise in out-of-pocket healthcare expenditure, and the increase in the number of hospitals. As per this research report, Worldwide Biopsy Devices Market is likely to grow at a CAGR of 6.86% by 2027.
Regional Analysis – North America is the leading revenue contributor in the Biopsy Devices Industry
Further, North America is the leading revenue contributor in the biopsy devices market. It is due to the large availability of trained medical professionals, well-developed infrastructure facilities, and the presence of a majority of key players. Moreover, Asia Pacific is a promising destination for biopsy device manufacturers. Rapidly improving healthcare infrastructure in emerging Asia Pacific countries, coupled with high unmet patient needs and increasing incidence of breast cancer, is anticipated to stimulate the demand for biopsy devices. Our research suggests that the Global Biopsy Devices Market was US$ 2.2 Billion in 2020.
Companies are undertaking strategies, such as product launches within technological innovations and partnerships, to gain profits in the industry. For example: In 2021, Oprah Winfrey Network OWN YOUR HEALTH announced an exclusive partnership with Hologic’s Project. This partnership will bring awareness to the inequality of healthcare U.S. Black women get in the areas of breast, cervical, and uterine fibroids. It will give access to education and preventative tools using Hologic’s comprehensive research and resources. Besides, it will also share original content from celebrated OWN creative visionaries highlighting the authentic stories and voices of Black women.
Renub Research latest report “Biopsy Devices Market by Product (Biopsy Needles – Fine Aspiration Needles, Core Needles, Guidance Systems- Ultrasound-guided, Stereotactic-guided, Clinically-guided, Biopsy Guns, Reagents and kits, Others (Brushes, Curettes and Punches etc), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy, Others), Region ( North America, Europe, Asia Pacific, Rest of World), End – User (Diagnostic Center, Hospitals and others), Companies (Becton Dickinson and Company, Cardinal Health. Braun Melsungen AG, Inc, Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)”
Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/biopsy-devices-market-global-forecast-p.php
Product – Biopsy Devices Market has been covered from 5 Viewpoints:
1. Biopsy Needles
o Fine Aspiration Needles
o Core Needles
2. Guidance Systems
3. Biopsy Guns
4. Reagents and kits
5. Others (Brushes, Curettes and Punches etc)
Application – Biopsy Devices Market has been covered from 4 Viewpoints:
1. Breast Biopsy
2. Lung Biopsy
3. Prostate Biopsy
Region – Biopsy Devices Market has been covered from 4 Viewpoints:
1. North America
4. Rest of World
End – User – Biopsy Devices Market has been covered from 3 Viewpoints:
1. Diagnostic Center
• Company Initiatives
• Sales Analysis
1. Becton Dickinson and Company
2. Cardinal Health Inc.
3. Braun Melsungen AG, Inc
4. Olympus Corporation
5. Boston Scientific Corporation
6. Medtronic plc
7. Hologic, Inc.
Industry Related Reports:
Retinal Surgery Device Market: https://bit.ly/39TIO9L
Medical Ceramics Market: https://bit.ly/3F7OUBS
China Dental Market: https://bit.ly/3uAvoZR
Sleep Apnea Devices Market: https://bit.ly/3mdWNwV
Knee Replacement Market: https://bit.ly/3BdlmAB
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers, and executives to make informed and correct decisions.
Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.
Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)
Follow on Linkedin: https://www.linkedin.com/company/renub-research